Research |
![]() ![]() ![]() ![]() ![]() |
Serial Number | 79316990 |
Registration Number | 6841465 |
Mark Drawing Code | 4000: Illustration: Drawing with word(s)/letter(s)/number(s) in Block form |
2021-06-04 | Application Filed |
2021-08-05 | Location: INITIAL REVIEW/SERIALIZATION BRANCH(MAILROOM) |
2021-08-05 | Status: Live/Pending |
2021-08-06 | Transaction Date |
2022-09-13 | Trademark Registered |
Owner: | ![]() |
Entity Statement | Limited company (ltd.) |
Address | Main Building and Second Floor of No. 11 Building, Beishan Industrial Zone, Yantian District, Shenzhen 518083 Guangdong CN |
Legal Entity Type | |
Legal Entity State | CN |
Click the blue "Refresh" button to load certificates, specimines, application, and other documents.
International Codes: | 1 |
U.S. Codes: | 001,005,006,010,026,046 |
International Codes: | 5 |
U.S. Codes: | 005,006,018,044,046,051,052 |
Type Code | Type |
---|---|
GS0011 | Chemical preparations for scientific purposes, other than for medical or veterinary use; chemical reagents, other than for medical or veterinary purposes; bases [chemical preparations]; test paper, chemical; radioactive elements for scientific purposes; preparations of microorganisms, other than for medical and veterinary use; biological preparations, other than for medical or veterinary purposes; acids; chemical substances for analyses in laboratories, other than for medical or veterinary purposes; diagnostic reagents and preparations, except for medical or veterinary use |
GS0051 | Chemico-pharmaceutical preparations for medical purposes for detection, screening, diagnosis of cancer and genetic diseases; preparations of microorganisms for medical or veterinary use; enzyme preparations for medical purposes; biological tissue cultures for medical purposes; biochemical pharmaceuticals for medical purposes, namely, for the treatment of cancer and genetic diseases; blood products for medical purposes, namely, blood plasma and cord blood; medical diagnostic reagents; chemical reagents for medical or veterinary purposes; preparations for detecting genetic predispositions for medical purposes; bacterial preparations for medical and veterinary use |
Description | Date | Event Coding |
---|---|---|
SN ASSIGNED FOR SECT 66A APPL FROM IB | 2021-08-05 | 1 REPR M: |
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED IN TRAM | 2021-08-06 | 2 NWOS I:Incoming Correspondence |
APPLICATION FILING RECEIPT MAILED | 2021-08-10 | 3 MAFR O:Outgoing Correspondence |
ASSIGNED TO EXAMINER | 2021-12-07 | 4 DOCK D:Assigned to Examiner |
NON-FINAL ACTION WRITTEN | 2021-12-31 | 5 CNRT R:Renewal |
NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW | 2022-01-01 | 6 RFCR E:E-Mail |
REFUSAL PROCESSED BY MPU | 2022-01-20 | 7 RFRR P: |
NON-FINAL ACTION MAILED - REFUSAL SENT TO IB | 2022-01-20 | 8 RFCS P: |
TEAS CHANGE OF OWNER ADDRESS RECEIVED | 2022-01-29 | 9 COAR I:Incoming Correspondence |
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED | 2022-01-29 | 10 REAP I:Incoming Correspondence |
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED | 2022-01-29 | 11 ARAA I:Incoming Correspondence |
TEAS CHANGE OF CORRESPONDENCE RECEIVED | 2022-01-29 | 12 TCCA I:Incoming Correspondence |
APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED | 2022-01-29 | 13 CHAN I:Incoming Correspondence |
REFUSAL PROCESSED BY IB | 2022-02-06 | 14 RFNT P: |
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED | 2022-04-15 | 15 REAP I:Incoming Correspondence |
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED | 2022-04-15 | 16 ARAA I:Incoming Correspondence |
TEAS CHANGE OF CORRESPONDENCE RECEIVED | 2022-04-15 | 17 TCCA I:Incoming Correspondence |
NON-FINAL ACTION WRITTEN | 2022-05-13 | 18 CNRT R:Renewal |
NON-FINAL ACTION E-MAILED | 2022-05-13 | 19 GNRT O:Outgoing Correspondence |
NOTIFICATION OF NON-FINAL ACTION E-MAILED | 2022-05-13 | 20 GNRN O:Outgoing Correspondence |
TEAS RESPONSE TO OFFICE ACTION RECEIVED | 2022-05-20 | 21 TROA I:Incoming Correspondence |
CORRESPONDENCE RECEIVED IN LAW OFFICE | 2022-05-20 | 22 CRFA I:Incoming Correspondence |
TEAS/EMAIL CORRESPONDENCE ENTERED | 2022-05-20 | 23 TEME I:Incoming Correspondence |
EXAMINERS AMENDMENT -WRITTEN | 2022-05-25 | 24 CNEA R:Renewal |
EXAMINERS AMENDMENT E-MAILED | 2022-05-25 | 25 GNEA O:Outgoing Correspondence |
NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED | 2022-05-25 | 26 GNEN O:Outgoing Correspondence |
EXAMINER'S AMENDMENT ENTERED | 2022-05-25 | 27 XAEC I:Incoming Correspondence |
APPROVED FOR PUB - PRINCIPAL REGISTER | 2022-05-25 | 28 CNSA O:Outgoing Correspondence |
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED | 2022-06-08 | 29 NONP E:E-Mail |
PUBLISHED FOR OPPOSITION | 2022-06-28 | 30 PUBO A:Allowance for Publication |
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED | 2022-06-28 | 31 NPUB E:E-Mail |
REGISTERED-PRINCIPAL REGISTER | 2022-09-13 | 32 R.PR A:Allowance for Publication |
NOTICE OF REGISTRATION CONFIRMATION EMAILED | 2022-09-13 | 33 NRCC E:E-Mail |
TEAS SECTION 7 REQUEST RECEIVED | 2022-10-31 | 34 ES7R I:Incoming Correspondence |
FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB | 2022-12-13 | 35 FICR P: |
FINAL DISPOSITION PROCESSED | 2022-12-15 | 36 FIMP P: |
FINAL DISPOSITION NOTICE SENT TO IB | 2022-12-15 | 37 FICS P: |
FINAL DECISION TRANSACTION PROCESSED BY IB | 2023-01-09 | 38 FINO P: |
uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.
While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.
All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.